The newest coworking spot is in POST Houston.  Photo courtesy of Common Desk

A Texas-based coworking company has rolled out its fifth Houston-area location just on the edge of downtown.

Common Desk has opened in 32,000 square feet of space in the POST Houston, a recently renovated historic building built in 1934 at 401 Franklin St.

“Common Desk has built a homey office environment that integrates beautifully with the industrial architecture at POST Houston,” says Kirby Liu, director at Lovett Commercial, in a news release. “We couldn’t be more excited to welcome organizations big and small to office at our development.”

The POST Houston is on the edge of downtown. Photo via posthtx.com

The new location includes over 24,000 square feet of workspace, seven conference rooms, 43 private offices, a dedicated desk room, and shared coworking space. Additionally, Common Desk opened seven team suites on the first and second floors that are managed by CBRE. Tenants in these spaces will have access to Common Desk’s shared areas. Just like other locations, member amenities include:

  • Chat booths
  • A wellness room
  • Full kitchen bottomless drip coffee
  • Wifi access
  • Fiction Coffee espresso bar
  • A 32-seat training room on the first floor

POST Houston is the home to 713 Music Hall venue, POST Market food hall, and Outpost rooftop event space.

Founded in 2012, Common Desk has grown to 22 locations and counting in Dallas, Houston, Austin, Wilmington, and Raleigh. In Houston, the company has opened coworking space in five locations, including:

The company also has a location in Spring in City Place.

“We're incredibly excited to be a part of the POST Houston development and to provide an outlet for companies, entrepreneurs and freelancers to experience their workdays in such a magical and inspiring setting,” says Dawson Williams, head of real estate at Common Desk.

Common Desk in POST Houston has an espresso bar for coworkers. Photo courtesy of Common Desk

Simulation runs through June 30 downtown. Photo via Post Houston

Creative Houston art duo unveils dreamy new tech world in downtown's hottest destination

simulation stimulation

Aclever, Houston-based duo has unveiled a new digital art experience at downtown’s hottest hub. Creative technologist Billy Baccam and multidisciplinary artist Alex Ramos, founders of Input Output Creative Media Lab, have launched “Simulation,” the first artist residency at Post Houston. The show runs through June 30.

The creative team has transformed part of POST Houston's X atrium into a creative media lab. There, Baccam and Ramos have experimented with various kinds of emerging technologies to prototype and develop art experiences.

Mediums in the show include projection mapping, 3D printing, body tracking, camera vision, augmented reality, LEDs, and computer simulation, per a press release.

The “Simulation” layout utilizes the glass wall as an interface for the public to experience the art. Internally, viewers can see an amalgamation of machinery, wires, gizmos, and gadgets similar to the inner workings of a computer.

Externally, viewers can explore and interact with the art through the glass wall via body tracking sensors, augmented reality via QR codes, and just by merely watching. Various books, movies, and other memorabilia have been scattered throughout the space to showcase inspiration on the subject matter of simulations and their influence on culture, a release notes.

“We’re super excited to be able to share the art we have diligently been working on for ‘Simulation,’” the team notes in a statement. “We’ve been able to explore a variety of new mediums such as 3D printing and augmented reality while also getting a chance to dive deeper into our previous works based on projection mapping, interactivity, and computer simulations. As we continue to create, learn, and iterate, the pieces will also evolve to reflect our growth. We thank the public for engaging with our work and bringing about moments of joy and wonder.”

For more information on the duo, visit www.inputoutput.space or @1nput0utput on Instagram.

---

This article originally ran on CultureMap.

Post Houston will be site of one of the world's largest rooftop gardens. Photo courtesy of Lovett Commercial

Houston to be home to one of the world's largest rooftop gardens after downtown post office's renovations

Posting up

Downtown Houston will soon have one of the largest rooftop gardens and farms in the world, thanks to the innovative reimagining of a forgotten structure. The Barbara Jordan Post Office, the massive government building nestled in the Theater District, will be transformed into a bustling, dynamic, mixed-use complex that's meant to become the city's new urban ecosystem.

At an official groundbreaking, Lovett Commercial revealed the plans for the more than 550,000-square-foot building, which was formerly the epicenter of the city's mail system from 1936 to 2014. The post office will fittingly become Post Houston and will house a concert venue, retail and office concepts, restaurants, bars, an international market hall, and a flexible co-working space.

What's sure to be a buzzworthy draw are the Buffalo Bayou and downtown views from Skylawn, the sprawling five-acre rooftop park and sustainable organic farm that calls to mind downtown rooftop green spaces in New York City. The park is designed by Hoerr Schaudt, the landscape architects behind McGovern Centennial Park in the Museum District.

Foodies, take note: The rooftop farms offer a chance for in-house restaurants to source ingredients and create a farm-to-table experience.

Photo courtesy of Lovett Commercial

The roof promises striking downtown views.


Design-minded guests will delight in the three new atriums; the building will be surgically punctured to create the spaces to draw in existing light utilizing an ETFE roof system — the first in Houston. Each atrium will feature with a unique monumental staircase that will mark the space as coworking, culinary, or retail.

As a nod to Houston's booming arts and cultural scene, the building will house installations and exhibits by local and international artists and will host events, according to a release.

The complex is designed by the world-renowned architecture firm OMA along with partner Jason Long in collaboration with Houston-based Powers Brown Architecture. Diversity is a key theme, with myriad design elements and purposes — and it's apropos that the building is named for Barbara Jordan, Houston's beloved first African American modern-day state senator.

Other than the Day for Night festival, the site has been of interest to architecture and design circles, but has largely been an afterthought. But now, the shuttered post office could become one of Houston's most vibrant destinations with its ideal strategic location.

"This forward-thinking development is breaking away from the traditional model by creating a cultural epicenter that brings local and international cuisine, retail, art, music and innovation to our theatre district," said Mayor Sylvester Turner, in a statement.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.